Browsing: results
AtriCure (NASDAQ:ATRC) announced preliminary revenue for Q4 2024 is expected to be $124.3M, more than consensus of $119.54M, reflecting growth…
jurgenfrInsmed (NASDAQ:INSM) reported preliminary 2024 revenue results for its drug Arikayce and issued 2025 revenue guidance. The drugmaker said 2024…
Panama7Sanofi (NASDAQ:SNY) said that a Phase 3 study of its new subcutaneous formulation of Sarclisa in the treatment of multiple…
Between Ripple (XRP) and Cardano (ADA), an unexpected favorite has been identified for 2025 by ChatGPT. This surprising selection challenges…
Headwater Exploration (TSX:HWX:CA) on Monday, reported fourth quarter average production volumes of approximately 21,500 BOE/d and significant land expansion in…
IvelinRadkovAxsome Therapeutics (NASDAQ:AXSM) stock fell 12% Monday after the company reported mixed Phase 3 results for its drug AXS-05, or…
Diego Thomazini/iStock via Getty Images The S&P 500 (NYSEARCA:SPY) and the S&P 500 Equal Weight (RSP) are on track to…
SIR Royalty Income Fund press release (SRV.UN:CA): Q1 Food and beverage revenue from corporate restaurant operations decreased by 1.1% to C$58.7…
Steelcase press release (NYSE:SCS): Q3 Non-GAAP EPS of $0.30 beats by $0.08. Revenue of $794.9M (+2.2% Y/Y) misses by $38.5M.…
Brett_Hondow/iStock Editorial via Getty ImagesLennar (NYSE:LEN) shares slid 7.8% in Wednesday after-hours trading after the homebuilder turned in Q4 earnings…